Categories Uncategorized USA – How should CBO treat the “Most Favored Nation Model” interim final rule for Medicare Part B drugs? (Steven M. Lieberman, Brookings) Post author By Marco Emanuele Post date December 23, 2020 Sticky post How should CBO treat the “Most Favored Nation Model” interim final rule for Medicare Part B drugs? Tags CBO, Medicare, USA ← EDUCATION – 2020: A year of turmoil but also hope in education (Emiliana Vegas and Rebecca Winthrop, Brookings) → USA – The 2010s saw the lowest population growth in U.S. history, new census estimates show (William H. Frey, Brookings)
The Global EyeThe Global Eye